Internewscast
Image default
Business World News

Gilead says remdesivir coronavirus treatment reduces risk of death

A lab technician inspects filled vials of investigational coronavirus disease (COVID-19) treatment drug remdesivir at a Gilead Sciences facility in La Verne, California, U.S. March 11, 2020. Picture taken March 11, 2020.

Gilead Sciences Inc | Reuters

Gilead Sciences published new data Friday on its antiviral drug remdesivir that shows it reduced the risk of death for coronavirus patients by 62% compared with standard care alone.

The findings are being presented at the Virtual Covid-19 Conference as part of the 23rd International AIDS Conference, the company said.

This is breaking news. Please check back for updates.

Related posts

Leave a Comment